Skip to main content
ImmuneCited

Curcumin Chronic Inflammation

A

An umbrella meta-analysis of 10 studies with 5,870 participants demonstrates curcumin supplementation may significantly reduce CRP, IL-6, and TNF-alpha inflammatory markers. Piperine co-administration increases bioavailability by approximately 2,000%.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dcurcumin\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

結論

An umbrella meta-analysis of 10 studies with 5,870 participants demonstrates curcumin supplementation may significantly reduce CRP, IL-6, and TNF-alpha inflammatory markers. Piperine co-administration increases bioavailability by approximately 2,000%.

Key Study Findings

Review
Therapeutic potential of curcumin against pancreatitis.
Dose: None vs: None Outcome: curcumin effects on pancreatitis via anti-inflammatory and antioxidant … 効果: None None

対象集団: None

Review
Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus.
Dose: None vs: None Outcome: None 効果: None None

対象集団: review of dietary polyphenols in type 2 diabetes mellitus management

Review
Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications.
Dose: None vs: None Outcome: None 効果: None None

対象集団: review of plant-derived anti-inflammatory compounds for chronic disease prevention

Review
Pathological interplay of NF-κB and M1 macrophages in chronic inflammatory lung diseases.
Dose: None vs: None Outcome: None 効果: None None

対象集団: review of NF-kB and M1 macrophages in asthma, COPD, and pulmonary fibrosis

Review
Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.
Dose: None vs: None Outcome: None 効果: None None

対象集団: None

Review
Curcumin Modulation of the Gut-Brain Axis for Neuroinflammation and Metabolic Disorders Prevention and Treatment.
Dose: None vs: None Outcome: None 効果: None None

対象集団: None

Key Statistics

10

研究数

5870

参加者数

Positive

A

グレード

Referenced Papers

Antioxidants (Basel, Switzerland) 2025 8 件の引用
The Cochrane database … 2024 1 件の引用
Voprosy pitaniia 2022 1 件の引用
Biomedicines 2021 228 件の引用
Frontiers in medicine 2021 13 件の引用
Advances in experimental … 2021 6 件の引用
European journal of … 2020 91 件の引用
International journal of … 2019 137 件の引用
Frontiers in immunology 2018 200 件の引用
Current medicinal chemistry 2018 13 件の引用
Drug discovery today 2017 284 件の引用
Current pharmaceutical design 2017 168 件の引用
Molecules (Basel, Switzerland) 2015 539 件の引用
BioFactors (Oxford, England) 2013 288 件の引用
BioFactors (Oxford, England) 2013 167 件の引用
Current drug targets 2006 92 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
500-1,000 mg/day curcuminoids
enhancedabsorption:
150-500 mg/day (phytosome or piperine formulation)

上限量: No established UL; generally well-tolerated up to 8 g/day

研究で検討された用量

用量 期間 効果 N
None -- Positive --
None -- Positive --
None -- Positive --
None -- Neutral --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --

推奨摂取タイミング: With meals containing fat and black pepper (piperine) for enhanced absorption

Safety & Side Effects

報告されている副作用

  • Gastrointestinal discomfort (nausea, diarrhea, bloating)
  • Headache
  • Yellow stool discoloration
  • Iron absorption interference at very high doses

既知の相互作用

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Diabetes medications (may enhance blood sugar lowering)
  • CYP1A2, CYP3A4, CYP2D6 substrates (may inhibit metabolism)
  • Sulfasalazine and cyclophosphamide (may modify effects)

耐容上限摂取量: No established UL; generally well-tolerated up to 8 g/day

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Curcumin help with Chronic Inflammation?
Based on 10 studies with 5,870 participants, there is strong evidence from multiple clinical trials that Curcumin may support Chronic Inflammation management. Our evidence grade is A (Strong Evidence).
How much Curcumin should I take for Chronic Inflammation?
Studies have used various dosages. A commonly studied range is 500-1,000 mg/day curcuminoids. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Curcumin?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea, bloating), Headache, Yellow stool discoloration, Iron absorption interference at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Curcumin and Chronic Inflammation?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 10 peer-reviewed studies with 5,870 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。